10 Questions to Ask Your Surgeon Before Choosing a Premium Lens Upgrade

Premium intraocular lens upgrades can genuinely improve outcomes for the right patients. A toric lens can reduce astigmatism that otherwise limits distance vision. A well-chosen multifocal or EDOF lens can meaningfully reduce dependence on glasses for a patient whose lifestyle makes that a priority. These are not marketing claims — the evidence supports real benefits for appropriate candidates.

The operative words, however, are right patients and appropriate candidates. Premium IOLs are not universally better than the standard MSP-covered monofocal lens, and the decision to upgrade deserves the same careful thought you would give to any significant medical and financial commitment. Patients who feel rushed, overwhelmed, or under pressure to decide quickly are not in a position to give genuinely informed consent.

The ten questions below are designed to help you have a productive, evidence-grounded conversation with your surgeon — and to help you recognise when you are receiving honest, patient-centred guidance.

The 10 Questions

1. What is the evidence base for this specific lens?

Ask specifically about the type and quality of research supporting the lens being recommended. Is there an independent randomised controlled trial (RCT)? A Cochrane systematic review? Or is the evidence primarily from manufacturer-sponsored studies and case series? This is not a hostile question — it is a basic tenet of evidence-based medicine. A surgeon who welcomes it and answers it clearly is giving you the consultation you deserve.

The strongest evidence comes from independent RCTs, meta-analyses, and Cochrane reviews. Manufacturer-sponsored pivotal trials — while required for regulatory approval — may not fully reflect real-world outcomes, particularly for rare complications or long-term function.

2. Is this lens FDA or Health Canada approved, and for how long?

Regulatory approval is a necessary but not sufficient indicator of long-term safety and effectiveness. The FDA's approval process requires evidence of safety and efficacy for the approved indication — but the follow-up period in pivotal trials may be only 1–3 years. Health Canada approval applies to Canadian market availability. A lens that has been widely used for 20 years has a different evidence profile than one approved in the last five years, even if both are legitimately approved devices.

Ask when the lens was approved and what the typical follow-up period was in the pivotal trial data.

3. What are the realistic chances I will still need reading glasses?

Some patients are surprised after premium lens implantation that they still require glasses for certain tasks. "Spectacle independence" does not always mean glasses-free for all distances and all conditions. A monofocal lens set for distance will almost certainly require reading glasses. EDOF lenses typically reduce but do not eliminate near glasses dependence. Multifocal lenses offer the best near vision reduction — but even the best patients may still reach for glasses occasionally. Ask for realistic percentages based on published data, not best-case scenarios.

4. What are the most common side effects?

Ask specifically about dysphotopsias: halos, glare, and starbursts around lights at night. These are more common with multifocal IOLs than with EDOF or monofocal designs. The 2021 Cochrane meta-analysis (Cao et al.) confirmed higher rates of dysphotopsias with multifocal IOLs compared to standard lenses, though the majority of patients adapt over time. A small but meaningful percentage find these symptoms persistently bothersome enough to interfere with driving at night. You should hear about this risk honestly before making a decision, not after.

5. Am I a good candidate based on my corneal health and lifestyle?

Premium IOLs have specific candidacy requirements. Multifocal and EDOF lenses are generally not recommended for patients with corneal irregularities, significant pre-existing macular disease, advanced glaucoma, or conditions affecting contrast sensitivity. Toric lenses require stable, measurable astigmatism. Your surgeon should explain why they are recommending a specific lens for you — not just what they are recommending. If you have any of the above conditions, a premium lens may not serve you well even if it is technically implantable.

6. What happens if I am unhappy with the outcome?

Intraocular lens exchange — removal and replacement of an IOL — is possible but significantly more complex than the original surgery. It carries greater risk of complications including zonular damage, posterior capsule rupture, and corneal endothelial cell loss. While experienced surgeons can perform IOL exchanges successfully, it is not a routine procedure and is not something to rely on as a fallback. This reality makes initial lens selection all the more important.

7. Is the evidence for this lens from independent researchers, or primarily industry-funded?

Industry-funded research in ophthalmology and medical devices generally is a legitimate area of scientific inquiry — but it is also associated with a well-documented tendency toward more favourable outcome reporting compared to independently funded studies. This does not mean industry data is worthless, but it is a reason to look for corroborating independent evidence. Ask whether independent academic groups (universities, national health systems, Cochrane collaboration) have evaluated this specific lens.

8. What does the standard MSP-covered lens offer me, and what would I genuinely gain with the upgrade?

This is perhaps the most important question on the list. The answer should be specific to you: your eye measurements, your corneal astigmatism, your lifestyle needs, and your visual goals. "You would gain the possibility of reading without glasses in most lighting conditions" is a meaningful answer. "The standard lens is basic" is not a meaningful answer — the standard monofocal lens has the most extensive evidence base of any IOL, and it is the appropriate choice for a large proportion of patients.

9. Are there other patients similar to me I could speak with about their experience?

A surgeon who has implanted a particular premium lens in many patients may be willing to connect you with previous patients who have agreed to share their experience. This is not a formal part of the consent process, but peer experience can be a meaningful complement to clinical statistics — particularly for outcomes like halos and glare that are inherently subjective.

10. If you were in my position, what would you choose?

This question often produces the most candid and useful response of any. A surgeon who would choose the premium lens for themselves in your situation has a different kind of confidence in it than one who hesitates. Equally, a surgeon who says honestly "based on your eye measurements and lifestyle, I think the standard monofocal is the right choice for you" is giving you genuinely patient-centred advice. The willingness to make a personal recommendation — rather than deferring entirely — is a sign of both expertise and integrity.

Red Flags to Be Aware Of

While the vast majority of cataract surgeons provide honest, patient-centred care, it is worth knowing what pressure-based consultations can look like:

• Being given limited time to decide on a lens upgrade at the pre-operative visit
• Suggestions that the standard MSP-covered lens is "old technology" or "basic"
• Minimal discussion of the side effects or limitations of the recommended premium lens
• No discussion of the standard monofocal lens as a genuine option
• Difficulty getting clear answers to the questions above

A good surgeon welcomes all ten of these questions. The willingness to engage transparently with evidence, acknowledge limitations, and respect your autonomy to choose the standard lens without any pressure is the hallmark of honest, ethical ophthalmic care.